CDC: This year a menu of options against influenza

CDC: This year a menu of options against influenza

ATLANTA, Nov. 7 (UPI) -- A flu shot can reduce the risk a person gets the flu, make the flu less severe if caught and help those who can't be vaccinated, a U.S. health official says.
This year's flu shot: 2009 (H1N1), A(H3N2) and B/Massachusetts

This year's flu shot: 2009 (H1N1), A(H3N2) and B/Massachusetts

BETHESDA, Md., Oct. 10 (UPI) -- This year's flu vaccine will protect against three strains most likely to cause the flu, but some vaccines will have an additional strain, U.S. officials say.

Record amount of whooping cough in 50 yrs

ATLANTA, July 19 (UPI) -- U.S. whooping cough cases may reach the highest number in the last 50 years, with Washington state being hardest hit, health officials said.

Teen HPV vaccination rate remains stable

ATLANTA, Aug. 25 (UPI) -- U.S. teen vaccination rates are rising for tetanus, diphtheria and pertussis, and for meningitis, but not for human papillomavirus, officials say.
U.S. childhood immunization rates high

U.S. childhood immunization rates high

ATLANTA, Sept. 17 (UPI) -- Immunization rates for U.S. children ages 19- to 35-months for most routine vaccines remains at or more than 90 percent, health officials say.

CDC: U.S. teen vaccination rate increased

ATLANTA, Aug. 19 (UPI) -- U.S. teen vaccination rates, though improved, leave a lot to be desired, so if teens are uninsured parents should ask about free vaccines, officials say.

Surplus flu vaccine will be discarded

WASHINGTON, April 1 (UPI) -- U.S. officials say it is inevitable that a large amount of unused H1N1 vaccine will have to be thrown out once it has expired.

Ga. H1N1 'intense,' CDC urges vaccine

ATLANTA, March 29 (UPI) -- Particularly in Georgia, where H1N1 is circulating intensively, it's important for people to take advantage of the vaccine, federal health officials urge.

CDC: Plenty of H1N1 vaccine everywhere

ATLANTA, Jan. 7 (UPI) -- There are 136 million doses of H1N1 vaccine available for ordering by the states, U.S. health officials said Thursday.

CDC: 60 million in U.S. had H1N1 vaccine

ATLANTA, Dec. 22 (UPI) -- One in three people in the United States -- 60 million -- has received the H1N1 vaccine, but about half of Americans want the vaccine, health officials say.

CDC: H1N1 pneumococcal infection worrisome

ATLANTA, Nov. 26 (UPI) -- Federal health officials said they are seeing an increase in serious pneumococcal infections around the United States, a finding described as "worrisome."

CDC: H1N1 down some, but could return

ATLANTA, Nov. 20 (UPI) -- Influenza cases are down in some parts of the United States, but 43 states are still reporting activity, health officials said Friday.

CDC tells travelers to 'Stop, Wash and Go'

ATLANTA, Nov. 19 (UPI) -- Holiday get-togethers and traveling itself provide an ideal way for illness to spread, especially H1N1 flu, U.S. health officials said.
CDC estimates 22M had H1N1, 3,900 died

CDC estimates 22M had H1N1, 3,900 died

ATLANTA, Nov. 12 (UPI) -- An estimated 22 million people in the United States have become ill from H1N1 influenza and some 3,900 people have died, health officials said Thursday.

Double H1N1 vaccine, but still not enough

ATLANTA, Nov. 6 (UPI) -- Federal health officials said Friday that there is twice as much H1N1 vaccine -- 38 million doses -- available as two weeks ago.
Page 1 of 2

Rear Admiral Anne Schuchat, M.D., is the current Interim Deputy Director for Science and Public Health Program at the Centers for Disease Control and Prevention (CDC).

Anne Schuchat graduated with highest honors from Swarthmore College and with honors from Dartmouth Medical School. She served as resident and chief resident in internal medicine at New York University′s Manhattan VA Hospital before beginning her public health career at CDC as an Epidemic Intelligence Service (EIS) officer in NCID.

As Interim Deputy Director for Science and Public Health Program, Dr. Schuchat is focused on ensuring strong science and programmatic approaches are effectively integrated into planning across the agency. She has emphasized prevention of infectious diseases in children. Her emphasis on perinatal group B streptococcal disease prevention has led to an 80 percent reduction in newborn infections and a 75 percent narrowing of racial disparities among sufferers of this infectious disease. She has been instrumental in pre- and post-licensure evaluations of conjugate vaccines for bacterial meningitis and pneumonia and in accelerating availability of these new vaccines in resource-poor countries through WHO and the Global Alliance for Vaccines and Immunization.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Anne Schuchat."